Biogen Inc

NASDAQ: BIIB
$164.00
-$0.89 (-0.5%)
Real Time Data Delayed 15 Min.

BIIB Articles

The April 15 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will be buying back a sizable amount of stock.
The top analyst upgrades, downgrades and initiations seen on Friday included Best Buy, Biogen, China Mobile, Chipotle Mexican Grill, CNOOC, Conagra Brands, Kinder Morgan, Lumentum, Nike and Toll...
Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer’s disease after shares of Biogen Inc. (NASDAQ: BIIB) suffered handily with the announcement that it and...
Thursday was a very positive day for the broad U.S. markets. The S&P 500 and DJIA pushed higher in the session largely driven by the tech sector, although the major banks offered some resistance....
Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for Alzheimer’s disease.
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The transaction is expected to close by mid-year 2019.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and...
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
The top analyst upgrades, downgrades and initiations seen on Thursday included Agilent Technologies, American Water Works, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS and Walmart.